How do tirzepatide and semaglutide affect blood tests?
Tirzepatide (Mounjaro, Zepbound) and semaglutide (Wegovy, Ozempic) lowered average HbA1c and triglycerides in weight trials, including in people without diabetes. The US labels also report average rises in the pancreatic enzyme lipase, of up to 35% on Zepbound and 39% on Wegovy. Dehydration from stomach side effects can harm the kidneys and raise creatinine.
Which results tend to go down?
In the weight trials behind the US labels, average HbA1c (a measure of blood sugar over about three months) fell, even without diabetes.1,2
Tirzepatide. In the main US Zepbound weight trial, people without diabetes started with an average HbA1c of 5.6%. After 72 weeks it fell 0.4 points on each Zepbound dose, against 0.1 on placebo (a dummy injection). In a trial of people with type 2 diabetes, it fell 2.1 points, against 0.5.1 On Zepbound 15 mg in that trial, triglycerides (a blood fat) fell 29.1%, against 5.6%. HDL (“good” cholesterol) rose 8.0%, against a 0.7% fall.1
Semaglutide. In the main US Wegovy weight trial in people without diabetes, HbA1c started at 5.7% and fell 0.4 points over 68 weeks on Wegovy, against 0.2 on placebo. Triglycerides fell 21.9%, against 7.3%.2
Both US labels say these extra results were not tested as strictly as weight loss.1,2
Low blood sugar. The US Zepbound label says it lowers blood glucose and can cause low blood sugar (hypoglycaemia). In its diabetes trial, this happened to 10.3% of people also taking a sulfonylurea, against 2.1% of those not taking one. The label says lowering the insulin or sulfonylurea dose may cut the risk.1
Why might lipase, amylase or liver tests come back high?
Both US labels report that average levels of lipase and amylase, two enzymes made by the pancreas, rose during treatment.1,2
On Zepbound, amylase rose 20% to 25% and lipase 28% to 35%, against 2.1% and 5.8% on placebo.1 On Wegovy, amylase rose 15% to 16% and lipase 39%, with no such rise on placebo. In a Wegovy liver-disease trial, lipase above three times the upper limit of normal was found in 4.7%, against 1.3%.2 Both labels say the meaning of these rises is unknown when there are no other signs of an inflamed pancreas (pancreatitis).1,2
The US Wegovy label also reports liver tests. In a trial in children, the liver enzyme ALT rose to five times the upper limit of normal in 3%, against none on placebo. Some of these rises went with other factors, such as gallstones. In its heart-outcomes trial in adults, bilirubin reached three times the upper limit in 0.3%, against 0.2%.2
- Inflamed pancreas (pancreatitis) is a labelled risk. Its sign is severe stomach pain that may spread to the back, with or without being sick.1
- Kidney injury has been reported, mostly after dehydration from nausea, vomiting or diarrhoea.1
- Low blood sugar is more likely with insulin or a sulfonylurea.1
Can side effects change kidney results?
Yes. The US Zepbound label reports sudden kidney injury on Zepbound and GLP-1 medicines, mostly in people dehydrated by nausea, vomiting or diarrhoea.1
Some cases needed dialysis. The label advises checking kidney function in people with these side effects, especially when starting or raising the dose.1 The US Wegovy label also lists kidney injury among reports after approval.2
The NHS says kidney injury is found with a blood test for creatinine, a waste product made by muscles and cleared by the kidneys. A higher level than usual means the kidneys are not working as well.10 MedlinePlus, from the US National Library of Medicine, lists dehydration as one cause of high creatinine. It says a low level may be a sign of malnutrition or of muscle loss.11
What do people on GLP-1 medicines report about blood tests?
From public patient forums: 20 Reddit threads in r/Zepbound, r/Mounjaro, r/WegovyWeightLoss, r/Ozempic and r/mounjarouk, read October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Matches the label Several saw HbA1c or blood sugar fall, including people without diabetes. In the main US Zepbound weight trial, which left out people with diabetes, average HbA1c fell 0.4 points.1
- Label says otherwise Several saw cholesterol or triglycerides rise while losing weight, though several others saw them improve. In the main US Zepbound weight trial, average triglycerides fell and HDL rose. The tables give averages only, so they do not show how many people’s levels rose.1
- Matches the label Many found a flagged result had another explanation, such as another medicine, an electrolyte drink or gallstones. The US Wegovy label says some liver-test rises in its children’s trial went with other factors, such as gallstones.2
- Matches MedlinePlus Several had low creatinine and were told it reflected less muscle or protein, not kidney damage. MedlinePlus says low creatinine may be a sign of malnutrition or muscle loss.11
Advice people share
- Not studied Many suggest repeating an abnormal test, often after about three months, before drawing conclusions. We found no study of retesting on these medicines.
- Matches MedlinePlus Several suggest drinking enough before a blood test. MedlinePlus lists dehydration as one cause of high creatinine.11
- The NHS says otherwise Several describe starting supplements such as iron without a test. The NHS says a blood test comes first, and iron tablets are recommended if it shows a low red blood cell count.12
In your country
The trial results are the same everywhere. Which enzyme figures each country’s label prints differs.
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: The Australian Mounjaro label gives one average for its weight and sleep apnoea trials: amylase rose 23% and lipase 34%. In diabetes trials, amylase rose 33% to 38% and lipase 31% to 42%.9
Emergency number: 000
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: Health Canada’s Zepbound monograph gives average rises of 23% for amylase and 34% for lipase. Lipase above three times the upper limit of normal was seen in 1.5%, against 1.0% on placebo.7 In the Wegovy monograph, it was seen in 1.2%, against 0.8%.8
Emergency number: 911
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: The EU Mounjaro label gives average rises in its weight trials of 23% for amylase and 34% for lipase, against 2% and 6% on placebo.3 The EU Wegovy label gives no average rise. Its leaflet lists raised pancreatic enzymes as uncommon (up to 1 in 100 people), and the label says raised enzymes alone do not predict pancreatitis.4
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: The EU Mounjaro label gives average rises in its weight trials of 23% for amylase and 34% for lipase, against 2% and 6% on placebo.3 The EU Wegovy label gives no average rise. Its leaflet lists raised pancreatic enzymes as uncommon (up to 1 in 100 people), and the label says raised enzymes alone do not predict pancreatitis.4
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We could not open an Indian label, so this page relies on the US and EU labels.
Emergency number: 112
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We could not open a Saudi label, so this page relies on the US and EU labels.
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We could not open a UAE label, so this page relies on the US and EU labels.
Emergency number: 998 for an ambulance, or 999
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: The UK Mounjaro label gives average rises in the SURMOUNT weight trials of 23% for amylase and 34% for lipase, against 2% and 6% on placebo.5 The UK Wegovy label gives no average rise, and says raised enzymes alone do not predict pancreatitis.6
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The answer above applies.
Emergency number: 911
Contact your prescriber or a doctor right away if you have severe stomach pain that may spread to your back, with or without being sick,1 or signs of low blood sugar such as a cold sweat, cool pale skin, a fast heartbeat or shaking.4 Get urgent help too if you are peeing much less than usual, feel very thirsty or have swollen feet or legs.10
Read the full picture
Related questions
Sources
- Eli Lilly. Zepbound (tirzepatide) US prescribing information, sections 5.3, 5.7, 6.1, 14.1 (Studies 1 and 2, Table 3) and 17 (US label). PDF
- Novo Nordisk. Wegovy (semaglutide) US prescribing information, sections 6.1, 6.2 and 14.2 (Study 2, Table 13) (US label). DailyMed
- European Medicines Agency. Mounjaro (tirzepatide) summary of product characteristics, section 4.8 (EU SmPC). PDF
- European Medicines Agency. Wegovy (semaglutide) summary of product characteristics, sections 4.4 and 4.8, and package leaflet section 4 (EU SmPC). PDF
- Eli Lilly. Mounjaro KwikPen summary of product characteristics, section 4.8 (UK SmPC, emc). emc
- Novo Nordisk. Wegovy 2.4 mg FlexTouch summary of product characteristics, sections 4.4 and 4.8 (UK SmPC, emc). emc
- Eli Lilly Canada. Zepbound (tirzepatide injection) Product Monograph, abnormal laboratory findings (Table 3) (Health Canada label). PDF
- Novo Nordisk Canada. Wegovy (semaglutide injection) Product Monograph, section 8.4 (Table 5) (Health Canada label). PDF
- Eli Lilly Australia. Mounjaro (tirzepatide) Australian product information, adverse effects (pancreatic enzymes) (Australian PI). PDF
- NHS. Acute kidney injury (AKI). NHS
- MedlinePlus (US National Library of Medicine). Creatinine test. Updated 5 December 2023. MedlinePlus
- NHS. Iron deficiency anaemia. NHS
- American College of Emergency Physicians. Know when to go to the ER. ACEP
Last checked Nov 16, 2026 · Next review due Nov 16, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 16, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write